Evidence map›Paper›PMID 36981520›Full record

ArticleHealthcare (Basel, Switzerland)2023

Deep Learning-Based Prediction of Diabetic Retinopathy Using CLAHE and ESRGAN for Enhancement.

Ghadah Alwakid, Walaa Gouda, Mamoona Humayun

Full text read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Applications of generative adversarial networks in the diagnosis, prognosis, and treatment of ophthalmic diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ghadah AlwakidDepartment of Computer Science, College of Computer and Information Sciences, Jouf University, Sakakah 72341, Al Jouf, Saudi Arabia.ORCID 0000-0002-2708-2064
Walaa GoudaDepartment of Electrical Engineering, Faculty of Engineering at Shoubra, Benha University, Cairo 11672, Egypt.ORCID 0000-0001-6615-7658
Mamoona HumayunDepartment of Information Systems, College of Computer and Information Sciences, Jouf University, Sakakah 72341, Al Jouf, Saudi Arabia.ORCID 0000-0001-6339-2257

Funding

Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia project number 223202
6 · The paper itself

Abstract

Vision loss can be avoided if diabetic retinopathy (DR) is diagnosed and treated promptly. The main five DR stages are none, moderate, mild, proliferate, and severe. In this study, a deep learning (DL) model is presented that diagnoses all five stages of DR with more accuracy than previous methods. The suggested method presents two scenarios: case 1 with image enhancement using a contrast limited adaptive histogram equalization (CLAHE) filtering algorithm in conjunction with an enhanced super-resolution generative adversarial network (ESRGAN), and case 2 without image enhancement. Augmentation techniques were then performed to generate a balanced dataset utilizing the same parameters for both cases. Using Inception-V3 applied to the Asia Pacific Tele-Ophthalmology Society (APTOS) datasets, the developed model achieved an accuracy of 98.7% for case 1 and 80.87% for case 2, which is greater than existing methods for detecting the five stages of DR. It was demonstrated that using CLAHE and ESRGAN improves a model's performance and learning ability.

Indexed as

APTOSdiabetic retinopathyimage enhancementvision loss

Identifiers

PMID36981520
PMCPMC10048517

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read21
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.